Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc.（KRTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
krtx · 股价预测 · 25 位分析师（近3月）· FMP · 更新于 2025年3月9日
分析师评级与共识
基于过去 3 个月内 25 位华尔街分析师
Buy
25 位分析师
共识
评级分布
12 个月目标价
High
$330
Consensus
$258
-21.9% upside
Low
$150
Median: $272.5 · Last Close: $329.83
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$257.50
-21.9% upside
High Target
$330
0.1%
Low Target
$150
-54.5%
Current Price
$329.83
as of today
Based on analyst price targets, the KRTX stock price prediction for the next 12 months ranges from $150 to $330. The consensus KRTX price forecast of $257.50 implies -21.9% upside from the current price of $329.83.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $333.43 | ↑ 1.09% |
1-day model range: $333.02–$333.84. Peak: $333.84 (+1.09%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KRTX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-03-14 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-03-11 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-02-20 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2024-01-26 | Mizuho | Downgrade ↓ | Buy→Neutral |
| 2024-01-17 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-12-28 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2023-12-26 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-12-22 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2023-12-22 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2023-12-22 | Guggenheim | Downgrade ↓ | Buy→Neutral |
Wall Street analysts have recently issued updated ratings on Karuna Therapeutics, Inc. (KRTX) stock. Of the recent 138 rating actions, 0 were upgrades and 7 were downgrades. 25 analysts currently cover KRTX.
分析师推荐趋势
KRTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$57M
↓ 92.0% YoY
Revenue Next Year
$267M
↑ 371.2% YoY
EPS This Year
$-11.51
EPS Next Year
$-7.54
↓ 34.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast KRTX EPS of $-11.51 for the current fiscal year, based on estimates from 12 analysts. The KRTX revenue forecast is $57M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KRTX 股价预测由两类独立数据源支撑：来自 25 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KRTX 的共识目标价为 $257.50（-21.9% 上行空间），分析师共识为 Buy。
KRTX 的短期预测（明日）为 $333.43（+1.09%）。
Karuna Therapeutics, Inc. 在 NASDAQ 上市，代码 KRTX。KRTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 64% 对应 Buy 共识。
常见问题
KRTX 预测 · 8 个问题根据 25 位华尔街分析师，KRTX 的 12 个月平均目标价为 $257.50，最高 $330.00、最低 $150.00。若有图表，中位目标价可在上方查看。相对当前价 $329.83，隐含约 -21.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.